12 träffar

DrugSelective If-channel inhibitor in the sinus node
Ivabradine

…Accord Selective If-channel inhibitor in the sinus node The only drug that reduces heart rate without affecting contractility, blood pressure, or conduction — it inhibits…

DrugACE inhibitor
Enalapril

…ACE inhibitor Prodrug hydrolysed to enalaprilat. Reduces mortality in heart failure with reduced ejection fraction — the effect is dose-dependent, and underdosing is more often…

DrugLoop diuretic
Furosemide

…in the loop of Henle. The dose–response relationship is a threshold curve, not a line: below the threshold nothing happens, and in renal failure…

DrugAminopenicillin with extended Gram-negative spectrum
Amoxicillin

…role belongs to phenoxymethylpenicillin — but for treatment failure, recurrent otitis, otitis with concurrent purulent conjunctivitis, and as a suspension alternative in pneumonia in young children…

DrugNon-selective COX inhibitor with COX-2 predominance, phenylacetic acid derivative
Diclofenac

…with the most unfavourable cardiovascular profile in the class — the increase in risk for myocardial infarction, stroke, and heart failure resembles that of selective COX…

DrugSGLT2 inhibitor
Empagliflozin

…reduced heart failure events regardless of ejection fraction in EMPEROR-Reduced and EMPEROR-Preserved, and slowed renal function decline down to eGFR 20 in EMPA…

DrugIndirect thrombin and factor Xa inhibitor via antithrombin
Heparin (unfractionated)

…unfractionated heparin is the first choice in severe renal failure, in the bleeding-prone patient, and when surgery or thrombolysis may become necessary at short…

DrugLong-acting dihydropyridine calcium channel blocker
Amlodipine

…no clinically significant negative inotropic effect and can therefore be used in heart failure with reduced ejection fraction when blood pressure or angina requires it…

DrugHighly selective β₁-blocker
Bisoprolol

…most β₁-selective of the routinely used beta-blockers, with documented mortality benefit in heart failure from CIBIS-II. Bioavailability is close to 90 % and…

DrugAngiotensin II receptor blocker (ARB)
Candesartan

…benefit in heart failure (CHARM), and the first choice when an ACE inhibitor must be switched due to cough. The target dose in heart failure…

DrugSGLT2 inhibitor
Dapagliflozin

…reduced EF, and DAPA-CKD demonstrated slowed renal function decline and reduced mortality in chronic kidney disease with albuminuria, with or without diabetes. The dose…

DrugUltra-short-acting β₁-selective blocker
Esmolol

…20–30 minutes after the infusion ends, it is useful in patients where beta-blockade is desirable but risky — impending heart failure, obstructive lung disease…